Aarti Pharmalabs Ltd

Aarti Pharmalabs Ltd share price slipped 0.59% to Rs 879.7 after the company's net profit slipped by 6.13% to Rs 71.47 crore, while revenue from operations edged up 13.93% to Rs 610.45 crore in Q3FY26 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.58 lakh crore, easing 4.30%. It has inched up 3.87% over last one week and gained upto 0.06% in last one month while the market capitalization of Aarti Pharmalabs Ltd has marginally improved by 6.11% and 31.70% in the same period respectively. Profit before tax (PBT) of Aarti Pharmalabs Ltd stood at Rs 94.99 crore in Q3 FY26, surging by 145.52% year-on-year, and slipping 6.01% quarter-on-quarter. EBITDA came in at Rs 135 crore, expanding by 80.38% YoY and declining 0.72% sequentially. Total expenses went up by 17.71% to Rs 505.82 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 334.88 crore, soaring by 32.96% YoY, while employee benefits expense was at Rs 54.55 crore, improving by 8.41% YoY. For the TTM ended FY26, revenue from operations declined by 13.98% to Rs 1819.44 crore, while net profit plunged by 35.86% to Rs 174.71 crore, compared to previous TTM. EBITDA soared by 47069% to Rs 359.46 crore, and PBT tanked by 35.42% to Rs 232.92 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 261.93 crore in FY26, as against Rs 330.14 crore in FY25. Aarti Pharmalabs Ltd gained 4.29% in last one year, significantly outperforming the benchmark BSE Sensex which has reduced by 13.45% during the same period.

Aarti Pharmalabs Limited will hold a board meeting on Wednesday, October 28, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2026, along with the Limited Review Reports of the auditors, and the trading window for securities transactions will remain closed from October 1, 2026, to October 30, 2026, for the purpose of announcing the results.

Aarti Pharmalabs Limited informed the Bombay Stock Exchange and National Stock Exchange of India that it received a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, from MUFG Intime India Private Limited, formerly Link Intime India Private Limited, for the quarter ended September 30, 2026.

Aarti Pharmalabs Limited will close its trading window for securities transactions from October 1, 2026, until 48 hours after the announcement of its financial results for the quarter ending September 30, 2026, in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Aarti Pharma Labs informed the BSE and National Stock Exchange of India that G.M. Naidu, Manufacturing/Sr. General Manager and Senior Management Personnel, resigned from his position, effective August 31, 2026, due to personal commitments.

Aarti Pharmalabs Limited has set September 15, 2026, as the record date for the payment of a final dividend of Rs 2.00 per equity share, representing 40% of the Rs 5 face value, for the financial year 2025-26, subject to shareholder approval at the Annual General Meeting scheduled for September 22, 2026, with payment expected on or before October 20, 2026.

Hitachi Energy India Ltd, Sky Gold & Diamonds Ltd, One 97 Communications Ltd and Poly Medicure Ltd are among the other gainers in the BSE's 'A' group today, 10 August 2026.Aarti Pharmalabs Ltd spiked 20.00% to Rs 821.45 at 11:48 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 1.08 lakh shares were traded on the counter so far as against the average daily volumes of 7739 shares in the past one month. Hitachi Energy India Ltd soared 10.31% to Rs 35938. The stock was the second biggest gainer in 'A' group. On the BSE, 38776 shares were traded on the counter so far as against the average daily volumes of 7711 shares in the past one month. Sky Gold & Diamonds Ltd surged 8.04% to Rs 774.55. The stock was the third biggest gainer in 'A' group. On the BSE, 2.5 lakh shares were traded on the counter so far as against the average daily volumes of 71210 shares in the past one month. One 97 Communications Ltd advanced 7.91% to Rs 1555. The stock was the fourth biggest gainer in 'A' group. On the BSE, 4.77 lakh shares were traded on the counter so far as against the average daily volumes of 3.21 lakh shares in the past one month. Poly Medicure Ltd exploded 6.50% to Rs 1802.3. The stock was the fifth biggest gainer in 'A' group. On the BSE, 69567 shares were traded on the counter so far as against the average daily volumes of 6610 shares in the past one month.

Aarti Pharmalabs Limited informed the Bombay Stock Exchange and National Stock Exchange of India that Rajendra Vallabhaji Gogri, a Non-Executive Director and liable to retire by rotation at the upcoming Annual General Meeting, will not seek re-appointment due to personal goals and other commitments, concluding his tenure as Director at the close of business hours of the ensuing AGM.

Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 7 August 2026.

Aarti Pharmalabs has allotted 22,062 equity shares under ESOP on 25 June 2026. Post this allotment, the paid-up Equity share capital of the Company stands increased to Rs. 45,33,99,065 representing 9,06,79,813 fully paid-up equity shares of face value of Rs.5/- each.